Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
http://www.canada.com/life/Vancouver+researchers+funded+improve+treatment+options+prost ate+cancer/3901249/story.html Vancouver researchers funded to improve treatment options for prostate cancer By Larry Pynn, Vancouver Sun November 29, 2010 The Prostate Centre Photograph by: Handout, .. VANCOUVER - Two researchers with the Vancouver Prostate Centre will be employing a sophisticated new type of computer modelling in an attempt to hasten new treatment options for prostate cancer. Art Cherkasov and Paul Rennie have received $324,000 in funding, half of that from Genome BC and the rest from partners that include the Canadian Institutes of Health Research and the prostate centre. The researchers will employ a new field called computational chemogenomics, using computer modeling in virtual 3-D to predict how different chemicals or drugs will affect cancer tumours. Currently, prostate cancer is treated with drugs that either block or bind the male hormone receptor thereby effectively shrinking the tumour. For many men, the effectiveness of this type of treatment is temporary and the cancer cells become treatment resistant. To help create new prostate cancer drugs that overcome such drug-resistance issues, researchers will seek to identify a new class of chemicals that act on the male hormone receptor in a different way. They will examine more than 10 million compounds or chemicals looking for potential new drugs, using computational chemogenomics to screen the compounds using computer software to gauge the potential effectiveness of the chemicals in targeting prostate tumours. Rennie said this form of "virtual screening" could shave years off the typical discovery process for new drug candidates and allow scientists to identify and test the most promising chemical compounds more rapidly. Currently, it can take 10 years or more to bring a compound to the stage of testing in humans. The new process could also reduce medical costs. [email protected] © Copyright (c) The Vancouver Sun